• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, October 14, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

New data shows low risk nicotine product snus is 95 percent safer than smoking

Bioengineer by Bioengineer
June 16, 2017
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

EMBARGOED UNTIL [09.00 GMT Friday 16th June 2017, Warsaw, Poland] New data analysis presented today at the annual Global Forum on Nicotone (GFN) meeting demonstrates the potential of the low risk tobacco product snus in reducing the impact of tobacco related disease and death in Europe.

The latest evidence, presented by Peter Lee, epidemiologist and medical statistician, indicates that snus is at least 95% safer than smoking. Analysis by Lars Ramström, snus researcher in Sweden, shows that if snus were made available in Europe – where it is currently banned with the exception of Sweden – and similar use levels to Sweden were adopted, up to 320,000 premature deaths could be avoided among men every year.

Snus, a smokeless powdered tobacco, is more popular than smoking in Sweden. Its availability has led to a reduction in smoking and smoking related diseases with the 2017 EC EuroBarometer survey showing only 5% of Swedes being daily smokers compared with the European average of 24%. Correspondingly, Swedish men have Europe's lowest level of tobacco-related mortality, 152 per 100,000 compared with the European average of 373 per 100,000.

While 46% of deaths due to smoking result from respiratory diseases such as lung cancer, chronic obstructive pulmonary disease and pneumonia, there is no evidence that risk of these diseases is increased by using snus. Nor does snus appear to increase the risk of other smoking related diseases including heart disease, stroke and a range of cancers.

In addition, the public health benefits of snus vs. cigarettes are not only much lower, but the role of snus in both reducing initiation of smoking and increasing cessation of smoking is a key element in defeating the actual cause of tobacco-related ill-health caused by the cigarette.

Current European legislation does not allow snus to be marketed in any European country except Sweden. However, due to strong evidence behind its potentially life saving benefits, The New Nicotine Alliance (NNA), a UK consumer group supporting access to safer nicotine products, is calling for its legalization and has joined legal action case against the banning of snus, which has now been referred to the European Courts of Justice.

Gerry Stimson, Chair of the NNA stated, 'Snus is a tobacco product that has consistently been proven to be less harmful to health than cigarettes. The ban on snus limits smokers choices of safer alternatives and has a significant negative impact on public health'.

In its fourth year, the Global Forum on Nicotine is the only international conference to focus on the role of safer nicotine products that may help people switch from smoking. The theme of this year's meeting 'Reducing Harm, Saving Lives' is focused on examining the role of safer nicotine products in reducing the global health burden of smoking.

The tobacco epidemic is one of the biggest public health threats, killing more than 7 million people a year.ii There are currently 1 billion smokers worldwide, with nearly 80% of them living in low and middle income countries, where the burden of tobacco-related illness is greatest.

###

About GFN

The Global Forum on Nicotine (GFN) is the only international conference to focus on the role of safer nicotine products that may help people switch from smoking. First established in 2014 by the independent public health consultancy Knowledge-Action-Change (KAC), this is the fourth year that the conference has been run – each time in Warsaw, Poland.

About Knowledge-Action-Change (KAC)

KAC is an independent public health consultancy committed to the development and promotion of evidence-based policies and interventions in the field of substance use and related areas of public health and public policy.

Its founders (Prof Gerry Stimson and Paddy Costall) have long experience in research, service delivery and policy development in the field of drugs, alcohol and tobacco.

For further information please contact:

Priya Lakhani-Quiling
GFN Press Officer
E: [email protected]
T: +447957 234 632

Kasia Kowalczyk
Knowledge Action Change
E: [email protected]
T: +48660 44293

References

EuroBarometer No 458 May 2017, Report, Attitudes of Europeans towards tobaccoelectronic cigarettes. Last accessed 25/05/17

World Health Organization. http://www.who.int/mediacentre/factsheets/fs339/en/

Media Contact

Priya Lakhani-Quiling
[email protected]
44-795-723-4632
@gfnicotine

https://kachange.eu/

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

Network Analysis of DSM-5 Personality Traits in Youth

October 14, 2025

Mitochondrial and Psychosocial Stress Regulate Human FGF21

October 14, 2025

C9orf72 Repeats Hinder Microglial Response in ALS

October 14, 2025

Study Shows Chewable Supplement Reduces Kids’ Respiratory Infections

October 14, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1238 shares
    Share 494 Tweet 309
  • New Study Reveals the Science Behind Exercise and Weight Loss

    104 shares
    Share 42 Tweet 26
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    101 shares
    Share 40 Tweet 25
  • Revolutionizing Optimization: Deep Learning for Complex Systems

    92 shares
    Share 37 Tweet 23

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Network Analysis of DSM-5 Personality Traits in Youth

Calcium: A Potential Solution to Stability Challenges in Sodium-Ion Batteries

Selective CO2 Uptake in Fluorinated Crystals Mimics Dissolution

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 65 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.